NBC New York

Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind

On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...
TechCrunch

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...
Hosted on MSN

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
eWeek

‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help

Science, laboratory and people on computer for medical analysis, research and medicine development AI drug design and development company Isomorphic Labs announced on Monday that it raised $600 ...
Observer

Nobel Winner Demis Hassabis’s A.I. Startup Is Spending Heavily On Drug Discovery

Demis Hassabis received the Nobel Prize in chemistry last week. Toby Melville/POOL/AFP via Getty Images Isomorphic Labs was founded three years ago as a subsidiary of Google’s parent company Alphabet ...
The New York Times

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced Reporting from London Over the ...